References
<A NAME="RS03804ST-1">1</A>
Briel D.
Pharmazie
1990,
45:
895
<A NAME="RS03804ST-2">2</A>
Roeder T.
Degen J.
Gewecke M.
Eur. J. Pharmacol.
1998,
349:
171
<A NAME="RS03804ST-3">3</A>
Sipido VK,
Fernández-Gadea FJ,
Andrés-Gil JI,
Meert TF, and
Gil-Lopetegui P. inventors; PCT Int. Appl. WO 96 14320.
; Chem. Abstr. 1996, 125, 142705g
<A NAME="RS03804ST-4">4</A>
Andrés JI.
Alcázar J.
Alonso JM.
Díaz A.
Fernández J.
Gil P.
Iturrino L.
Matesanz E.
Meert TF.
Megens A.
Sipido VK.
Bioorg. Med. Chem. Lett.
2002,
12:
243
<A NAME="RS03804ST-5">5</A>
Andersen KE,
Olsen UB,
Andersen HS,
Hohlweg R,
Joergensen TK, and
Madsen P. inventors; PCT Int. Appl. WO 96 31482.
; Chem. Abstr. 1997, 126, 8148v
<A NAME="RS03804ST-6">6</A>
Joergensen TK,
Andersen KE,
Andersen HS,
Hohlweg R,
Madsen P, and
Olsen UB. inventors; PCT Int. Appl. WO 96 31497.
; Chem. Abstr. 1997, 126, 8146t
<A NAME="RS03804ST-7">7</A>
Brugnara C,
Halperin J,
Bellott EMJr,
Froimowitz M,
Lombardy RJ,
Clifford JJ,
Gao Y.-D,
Haidar RM,
Kelleher EW,
Kher FM,
Moussa AM,
Sachdeva Y,
Sun M,
Taft HN,
Lencer WI, and
Alper S. inventors; PCT Int. Appl. WO 99 26628.
; Chem. Abstr. 1999, 131, 18936t
<A NAME="RS03804ST-8">8</A>
Fukumi H,
Sakamoto T,
Sugiyama M,
Iizuka Y, and
Yamaguchi T. inventors; U.S. US 5476848.
; Chem. Abstr. 1996, 124, 261063k
<A NAME="RS03804ST-9">9</A>
Sinha AK.
Nizamuddin S.
Ind. J. Chem., Sect. B
1984,
23:
83
<A NAME="RS03804ST-10A">10a</A>
Sasakura K.
Sugasawa T.
Heterocycles
1981,
15:
421
<A NAME="RS03804ST-10B">10b</A>
Lypacewicz MK,
Poslinska-Bucewka H,
Smolinska J,
Wasiak T,
Sosinska D,
Mostrak M,
Trzpil B, and
Paszkowski S. inventors; Pol. PL 175287.
; Chem. Abstr. 1999, 130, 296698x
<A NAME="RS03804ST-10C">10c</A>
Stappers F.
Broeckx R.
Leurs S.
Van den Bergh L.
Agten J.
Lambrechts A.
Van den Heurel D.
De Smaele D.
Org. Proc. Res. Develop.
2002,
6:
911
<A NAME="RS03804ST-11A">11a</A>
Moriconi EJ.
Maniscalco IA.
J. Org. Chem.
1972,
37:
208
<A NAME="RS03804ST-11B">11b</A>
Sinha AK.
Nizamuddin S.
Ind. J. Chem., Sect. B
1984,
23:
165
<A NAME="RS03804ST-12">12</A>
Kouznetsov V.
Palma AR.
Salas S.
Vargas LY.
Zubkov FI.
Varlamov AV.
Martínez JR.
J. Heterocycl. Chem.
1997,
34:
1591
<A NAME="RS03804ST-13">13</A>
Palma AR.
Rozo W.
Stashenko E.
Molina D.
Kouznetsov V.
J. Heterocycl. Chem.
1998,
35:
183
<A NAME="RS03804ST-14">14</A>
Kouznetsov V.
Palma A.
Rozo W.
Stashenko E.
Bahsas A.
Amaro-Luis J.
Tetrahedron Lett.
2000,
41:
6985
<A NAME="RS03804ST-15">15</A>
Varlamov A.
Kouznetsov V.
Zubkov F.
Chernyshev A.
Alexandrov G.
Palma A.
Vargas L.
Salas S.
Synthesis
2001,
849
<A NAME="RS03804ST-16">16</A>
Palma A.
Salas S.
Kouznetsov V.
Stashenko E.
Montenegro NG.
Fontela GA.
J. Heterocycl. Chem.
2001,
38:
837
<A NAME="RS03804ST-17">17</A>
Kouznetsov V.
Palma A.
Rozo W.
Stashenko E.
Bahsas A.
Amaro-Luis J.
Synth. Commun.
2002,
32:
2965
<A NAME="RS03804ST-18">18</A>
Baxter EW.
Labaree D.
Ammon HL.
Mariano PS.
J. Am. Chem. Soc.
1990,
112:
7682
<A NAME="RS03804ST-19">19</A>
Barta NS.
Cook GR.
Landis MS.
Stille JR.
J. Org. Chem.
1992,
57:
7188
<A NAME="RS03804ST-20">20</A>
Lai G.
Anderson WK.
Tetrahedron Lett.
1993,
34:
6849
<A NAME="RS03804ST-21">21</A>
Stroh R.
Ebersberger J.
Haberland H.
Hahn W.
Angew. Chem.
1957,
69:
124
<A NAME="RS03804ST-22">22</A>
Borch RF.
Bernstein MD.
Durst HD.
J. Am. Chem. Soc.
1971,
93:
2897
<A NAME="RS03804ST-23">23</A>
Anderson WK.
Lai G.
Synthesis
1995,
1287
<A NAME="RS03804ST-24">24</A>
Spectral Data for Selected Compounds 3.
Compound 3b: 1H NMR (400 MHz, CDCl3): δ = 3.29 (2 H, d, J = 6.0 Hz, -CH2-), 4.10 (1 H, br s, NH), 4.34 (2 H, s, N-CH2-), 5.15 (2 H, m, =CH2), 5.95 (1 H, m, -CH=), 6.54 (1 H, d, J = 8.0 Hz, 6-H), 7.06 (1 H, d, J = 2.0 Hz, 3-H), 7.08 (1 H, dd, J = 8.0, 2.0 Hz, 5-H), 7.30-7.43 (5 H, m, H-phenyl). 13C NMR (100 MHz, CDCl3): δ = 36.1 (-CH2-), 48.2 (N-CH2-), 111.8 (6-C), 116.9 (=CH2), 122.0 (4-C), 125.2 (2-C), 127.3 (ortho-C), 127.4 (5-C), 128.7 (3-C), 129.0 (para-C), 129.5 (meta-C), 135.0 (-CH=), 139.0 (1′-C), 144.6 (1-C). MS (EI): m/z (%) = 257 (35Cl, 8) [M+], 242 (<1), 228 (1), 180 (11), 166 (26), 152 (11), 131 (40), 91 (100), 77 (10).
Compound 3c: 1H NMR (400 MHz, CDCl3): δ = 3.32 (2 H, d, J = 6.4 Hz, -CH2-), 4.06 (1 H, br s, NH), 4.34 (2 H, s, N-CH2-), 5.15 (2 H, m, =CH2), 5.97 (1 H, m, -CH=), 6.56 (1 H, dd, J = 9.0, 5.0 Hz, 6-H), 6.83 (1 H, d, J = 3.0 Hz, 3-H), 6.85 (1 H, dd, J = 9.0, 3.0 Hz, 5-H), 7.30-7.39 (5 H, m, H-phenyl). 13C NMR (100 MHz, CDCl3): δ = 36.2 (-CH2-), 48.7 (N-CH2-), 111.5 (d, J = 10.0 Hz. 6-C), 113.4 (d, J = 20.0 Hz, 3-C), 116.5 (d, J = 20.0 Hz, 5-C), 116.9 (=CH2), 125.3 (d, J = 10.0 Hz, 2-C), 127.2 (para-C), 127.5 (ortho-C), 128.5 (meta-C), 135.1 (-CH=), 139.3 (1′-C), 142.3 (1-C), 155.6 (d, J = 206.1 Hz, 4-C). MS (EI):
m/z (%) = 241 (28) [M+], 212 (8), 198 (4), 164 (9), 150 (66), 135 (17), 91 (100), 77 (6), 65 (21).
Compound 3d: 1H NMR (400 MHz, CDCl3): δ = 2.44 (3 H, s, 2-CH3), 3.29 (2 H, dt, J = 6.0, 1.6 Hz, -CH2-), 3.04 (1 H, br s, NH), 4.09 (2 H, s, N-CH2-), 5.05 (2 H, m, =CH2), 5.93 (1 H, m, -CH=), 6.95 (1 H, d, J = 8.0 Hz, 5-H), 7.07 (1 H, d, J = 8.0 Hz, 4-H), 7.33-7.40 (5 H, m, H-phenyl). 13C NMR (100 MHz, CDCl3): δ = 15.6 (2-CH3), 36.3 (-CH2-), 53.6 (N-CH2-), 116.9 (=CH2), 123.4 (4-C), 127.4 (ortho-C), 127.8 (5-C), 128.3 (para-C), 128.6 (meta-C), 129.4 (3-C), 130.4 (6-C), 133.7 (2-C), 136.5 (-CH=), 139.0 (1′-C), 147.4 (1-C).
MS (EI): m/z (%) = 271 (35Cl, 11) [M+], 256 (2), 242 (4), 194 (7), 180 (33), 166 (18), 145 (46), 130 (14), 115 (8), 91
(100), 77 (8), 65 (22).
<A NAME="RS03804ST-25">25</A>
NMR and Analytical Data for Compounds 4.
Compound 4a: IR (KBr): 3405 cm-1. 1H NMR (400 MHz, CDCl3): δ = 0.91 (3 H, t, J = 7.4 Hz, 13-H), 2.17 (2 H, m, 12-H), 3.69 (1 H, t, J = 7.3 Hz, 11-H), 4.00 (1 H, d, J = 14.8 Hz, 6-HB), 4.95 (1 H, d, J = 14.8 Hz, 6-HA), 6.50 (1 H, d, J = 8.0 Hz, 4-H), 6.67 (1 H, td, J = 8.0, 1.0 Hz, 2-H), 6.96 (1 H, td, J = 8.0, 1.0 Hz, 3-H), 7.12 (1 H, dd, J = 8.0, 1.0 Hz, 1-H), 7.19-7.30 (4 H, m, 7-H-10-H). 13C NMR (100 MHz, CDCl3): δ = 13.0 (13-C), 31.6 (12-C), 51.1 (6-C), 54.8 (11-C), 117.9 (4-C), 118.2 (2-C),
127.2 (3-C), 127.6-129.5 (7-C-10-C), 130.2 (11a-C), 130.8 (1-C), 136.5 (6a-C), 142.1
(10a-C), 146.2 (4a-C). MS (EI): m/z (%) = 223 (14) [M+], 194 (100), 178 (8), 165 (11), 116 (10), 96 (10). Anal. Calcd for C16H17N: C, 86.06; H, 7.67; N, 6.27. Found: C, 86.13; H, 7.81; N, 6.14.
Compound 4b: IR (KBr): 3406 cm-1. 1H NMR (400 MHz, CDCl3): δ = 0.91 (3 H, t, J = 7.3 Hz, 13-H), 2.14 (2 H, m, 12-H), 3.63 (1 H, t, J = 7.7 Hz, 11-H), 4.17 (1 H, d, J = 14.4 Hz, 6-HB), 4.77 (1 H, d, J = 14.4 Hz, 6-HA), 6.40 (1 H, d, J = 8.5 Hz, 4-H), 6.91 (1 H, dd, J = 8.5, 2.3 Hz, 3-H), 7.10 (1 H, d, 2.3 Hz, 1-H), 7.12-7.34 (4 H, m, 7-H-10-H). 13C NMR (100 MHz, CDCl3): δ = 13.3 (13-C), 31.5 (12-C), 49.5 (6-C), 51.5 (11-C), 119.4 (4-C), 122.9 (2-C),
127.4 (3-C), 127.4-128.7 (7-C-10-C), 129.1 (11a-C), 130.7 (1-C), 136.5 (6a-C), 142.0
(10a-C), 145.1 (4a-C). MS (EI): m/z (%) = 257 (35Cl, 17) [M+], 228 (100), 193 (46), 165 (17), 115 (6), 89 (5). Anal. Calcd for C16H16ClN: C, 74.56; H, 6.26; N, 5.43. Found: C, 74.38; H, 6.49; N, 5.35.
Compound 4c: IR (KBr): 3429 cm-1. 1H NMR (400 MHz, CDCl3): δ = 0.91 (3 H, t, J = 7.1 Hz, 13-H), 2.18 (2 H, m, 12-H), 3.76 (1 H, t, J = 7.6 Hz, 11-H), 4.20 (1 H, d, J = 14.6 Hz, 6-HB), 4.71 (1 H, d, J = 14.6 Hz, 6-HA), 6.49 (1 H, dd, J = 8.0, 5.0 Hz, 4-H), 6.72 (1 H, ddd, J = 8.0, 3.0 Hz, 3-H), 6.82 (1 H, dd, J = 10.0, 3.0 Hz, 1-H), 7.13-7.22 (4 H, m, 7-H-10-H). 13C NMR (100 MHz, CDCl3): δ = 12.9 (13-C), 30.8 (12-C), 49.7 (6-C), 53.1 (11-C), 113.7 (d, J = 20 Hz, 3-C), 116.7 (d, J = 20 Hz, 1-C), 119.5 (d, J = 10 Hz, 4-C), 126.8 (8-C), 127.4 (9-C), 128.2 (7-C), 129.1 (10-C), 130.0 (11a-C),
136.5 (6a-C), 141.3 (10a-C), 142.5 (4a-C), 156.4 (d, J = 230 Hz, 2-C). MS (EI): m/z (%) = 241 (17) [M+], 212 (100), 196 (15), 183 (17), 165(10), 116 (9). Anal. Calcd for C16H16FN: C, 79.64; H, 6.68; N, 5.80.Found: C, 79.70; H, 6.80; N, 5.65.
Compound 4d: IR (KBr): 3446 cm-1. 1H NMR (400 MHz, CDCl3): δ = 0.96 (3 H, t, J = 7.4 Hz, 13-H), 2.20 (3 H, s, 4-CH3), 2.23 (2 H, m, 12-H), 3.84 (1 H, t, J = 7.6 Hz, 11-H), 4.09 (1 H, br s, N-H), 4.3 (1 H, d, J = 14.6 Hz, 6-HB), 4.90 (1 H, d, J = 14.6 Hz, 6-HA), 6.78 (1 H, d, J = 8.3 Hz, 2-H), 6.92 (1 H, d, J = 8.3 Hz, 1-H), 7.18-7.29 (4 H, m, 7-H-10-H). 13C NMR (100 MHz, CDCl3): δ = 11.9 (13-C), 13.3 (4-CH3), 29.9 (12-C), 48.0 (6-C), 52.5 (11-C), 117.5 (3-C), 120.3 (2-C), 124.9 (4-C), 125.9
(9-C), 126.5 (7-C), 127.0 (8-C), 127.7 (10-C), 127.8 (1-C), 131.8 (11a-C), 135.3 (6a-C),
140.9 (10a-C), 144.4 (4a-C). MS (EI): m/z (%) = 271 (35Cl, 13) [M+], 242 (100), 227 (6), 207 (31), 191 (10), 178 (11), 165 (8), 152 (6), 139 (2), 89
(4). Anal. Calcd for C17 H18ClN: C, 75.13; H, 6.68; N, 5.15. Found: C, 75.29; H, 6.83; N, 5.08.